Tax Law

Regulatory Compliance Sales Forecasting International Relations Healthcare Policy Income Tax Department Customs Pharmaceuticals Tariffs Taxation Corporate Governance

10 ARTICLES

last mo.

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

The pharmaceutical giant posts 10% revenue growth, accelerates US manufacturing and R&D plans, and faces legal scrutiny in China over tax and data issues.

3 ARTICLES

2mo ago

IndiGo Challenges ₹944 Crore Tax Penalty, Citing Legal Misunderstanding